In #4918 models (high BPTF expression), the gross tumor weight was significantly lower in the erlotinib plus AU‐1 treatment group than that in the vehicle‐, erlotinib‐, or AU‐1 treatment groups (Figure 8e). The gene discussed is BPTF; the disease is neoplasm.